CoChat
Sign Up
Cited by 2,126Pain Mechanisms and TreatmentsPain Management and TreatmentPain Management and Opioid Use

The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.

Pharmacologic management of neuropathic pain: Evidence-based recommendations

Dworkin, Robert H., O’Connor, Alec B., Backonja, Miroslav, Farrar, John T., Finnerup, Nanna B., Jensen, Troels S., Kalso, Eija A., Loeser, John D., Miaskowski, Christine, Nurmikko, Turo J., Portenoy, Russell K., Rice, Andrew S.C., Stacey, Brett R., Treede, Rolf-Detlef, Turk, Dennis C., Wallace, Mark S.·2007·Pain
DOI 10.1016/j.pain.2007.08.033
Open this paper in CoChat — free account

Abstract

Patients with neuropathic pain (NP) are challenging to manage and evidence-based clinical recommendations for pharmacologic management are needed. Systematic literature reviews, randomized clinical trials, and existing guidelines were evaluated at a consensus meeting. Medications were considered for recommendation if their efficacy was supported by at least one methodologically-sound, randomized clinical trial (RCT) demonstrating superiority to placebo or a relevant comparison treatment. Recommendations were based on the amount and consistency of evidence, degree of efficacy, safety, and clinical experience of the authors. Available RCTs typically evaluated chronic NP of moderate to severe intensity. Recommended first-line treatments include certain antidepressants (i.e., tricyclic antidepressants and dual reuptake inhibitors of both serotonin and norepinephrine), calcium channel alpha2-delta ligands (i.e., gabapentin and pregabalin), and topical lidocaine. Opioid analgesics and tramadol are recommended as generally second-line treatments that can be considered for first-line use in select clinical circumstances. Other medications that would generally be used as third-line treatments but that could also be used as second-line treatments in some circumstances include certain antiepileptic and antidepressant medications, mexiletine, N-methyl-D-aspartate receptor antagonists, and topical capsaicin. Medication selection should be individualized, considering side effects, potential beneficial or deleterious effects on comorbidities, and whether prompt onset of pain relief is necessary. To date, no medications have demonstrated efficacy in lumbosacral radiculopathy, which is probably the most common type of NP. Long-term studies, head-to-head comparisons between medications, studies involving combinations of medications, and RCTs examining treatment of central NP are lacking and should be a priority for future research.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.pain.2007.08.033

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Flagged first, then by citations

1 of the 139 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

See all 2,126

Related

See all

Metadata

Authors
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., Portenoy, R. K., Rice, A. S. C., Stacey, B. R., Treede, R.-D., Turk, D. C., & Wallace, M. S.
Affiliations
  • University of Wisconsin–Madison (US)
  • University of Pennsylvania (US)
  • Aarhus University Hospital (DK)
  • Helsinki University Hospital (FI)
  • University of Washington (US)
  • University of California, San Francisco (US)
  • University of Liverpool (GB)
  • Mount Sinai Beth Israel (US)
  • Imperial College London (GB)
  • Oregon Health & Science University (US)
  • Johannes Gutenberg University Mainz (DE)
  • University of California San Diego (US)
Corresponding author
Dworkin, Robert H.
ORCID
Venue
Pain
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2007-12
Volume
132
Issue
3
Pages
237-251
ISSN
0304-3959 (ISSN-L)
DOI
10.1016/j.pain.2007.08.033
OpenAlex
W2094310013
Cited by
2,126
References
139
Citations by year
2026: 35 · 2025: 48 · 2024: 54 · 2023: 56 · 2022: 53 · 2021: 87 · 2020: 95 · 2019: 103 · 2018: 101 · 2017: 136 · 2016: 141 · 2015: 160 · 2014: 157 · 2013: 171 · 2012: 147
FWCI
13.55
Type
journal article
Language
en
Open access
closed
Locations
  • Pain (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
neuropathic pain, pharmacological management, antidepressants, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, gabapentin, pregabalin, topical lidocaine, opioid analgesics, tramadol, antiepileptic drugs, mexiletine, NMDA receptor antagonists, topical capsaicin, lumbosacral radiculopathy, central pain, treatment guidelines
MeSH terms
Animals, Health Planning Guidelines, Humans, Neuralgia, Pain, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review